Author(s):
Manohar D. Kengar, Amit A. Jadhav, Rahul P. Jadhav, Prathmesh L. Jarag, Sanmati D. Shete
Email(s):
manojkengar200@gmail.com
DOI:
10.5958/2231-5675.2019.00008.5 
Address:
Manohar D. Kengar*, Amit A. Jadhav, Rahul P. Jadhav, Prathmesh L. Jarag, Sanmati D. Shete
Rajarambapu College of Pharmacy, Kasegaon, Dist – Sangli, Maharashtra, India – 415404
*Corresponding Author
Published In:
Volume - 9,
Issue - 1,
Year - 2019
ABSTRACT:
The H1NI flu infection is novel influenza virus do not differ from those of seasonal human influenza, there is a continued need for sub typing and laboratory confirmation according to WHO estimates, 1/3rd of the world’s population will be affected with H1N1flu within two years in India. The most common cause of H1N1viruse to death from the virus is respiratory failure, but other causes of mortality include sepsis, dehydration and electrolyte imbalance. WHO revised the phase descriptions in 2009 and has retained the use of six phases in regards to pandemics to allow for the incorporation of new recommendations and approaches into existing national preparedness and response plans. Prevention of transmission from pig to human Swine can be infected by both avian and human influenza strains of influenza, and therefore are hosts where the antigenic shifts can occur that create new influenza strains and verious medicin available in market to triet the H1N1 flu.
Cite this article:
Manohar D. Kengar, Amit A. Jadhav, Rahul P. Jadhav, Prathmesh L. Jarag, Sanmati D. Shete. Swine Flu and its Recent Medicines. Asian J. Pharm. Ana. 2019; 9(1):30-36. doi: 10.5958/2231-5675.2019.00008.5
Cite(Electronic):
Manohar D. Kengar, Amit A. Jadhav, Rahul P. Jadhav, Prathmesh L. Jarag, Sanmati D. Shete. Swine Flu and its Recent Medicines. Asian J. Pharm. Ana. 2019; 9(1):30-36. doi: 10.5958/2231-5675.2019.00008.5 Available on: https://ajpaonline.com/AbstractView.aspx?PID=2019-9-1-18